|Articles|December 1, 2006

Pharmacy Times

  • Volume 0
  • 0

ASPIRIN UNDER STUDY FOR ANTICANCER EFFECTS

Researchers are currently studying the possibleanticancer effects of aspirin. Aspirinblocks cyclooxygenase (COX), which helpsrestrict the blood supply to tumors, therebylimiting tumor growth. The studies of aspirininvolved exposing blood vessel cells to aspirinor COX-2 inhibitors like celecoxib. Aspirin athigh doses caused death of the blood vesselcells. This effect was not seen with standarddoses of aspirin or with COX-2 inhibitors.Investigators plan to continue studying theunderlying mechanism of aspirin's effect inorder to identify new targets for cancer drugs.

Dr. Garrett is a clinical pharmacistpractitioner at Cornerstone Health Carein High Point, NC.

Articles in this issue

about 19 years ago

Making Dry Eye Disappear

about 19 years ago

Help for Chapped Lips

about 19 years ago

can you READ these Rxs?

about 19 years ago

compounding HOTLINE

about 19 years ago

Drug Diversion in Vermont

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME